Phase II study of low dose (LD) and high dose (HD) premarin in androgen independent prostate cancer (AIPC)
Pomerantz M, Manola J, Taplin M, Bubley G, Inman M, Lowell J, Kantoff P, Oh W. Phase II study of low dose (LD) and high dose (HD) premarin in androgen independent prostate cancer (AIPC). Journal Of Clinical Oncology 2006, 24: 4560-4560. DOI: 10.1200/jco.2006.24.18_suppl.4560.Peer-Reviewed Original ResearchAndrogen-independent prostate cancerLow dosesHigh dosesLD armProgressive androgen-independent prostate cancerHD armMedian time to progressionClinical predictors of responseStudy of low doseGrade 3 toxicityPatients treated with LDProphylactic breast irradiationPSA response rateTime to progressionIndependent prostate cancerPhase II studyStage of accrualPredictors of responseCorrelates of treatment responseWarfarin 1 mgDose of PremarinBreast irradiationProphylactic warfarinTransdermal estradiolMedian PSA
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply